Replies to post #1007 on Incannex Healthcare Ltd (IXHL)

[luckydude777]

Here, I believe, suggests this stock is WAAAAAAAAAAAAAAYYYYYYYYYYYYYYYY undervalued, and could charge upwards in a New York second as this brief clip speaks of:

"With an active FDA Investigational New Drug (IND) application in place, Incannex is preparing for a larger, multi-jurisdiction Phase 2 trial and exploring partnerships to expand global access."

[otterman]

LOL, everyones fault but yours. 🤣🤣🤣

[Citrati]

ANSWER to delisting process.

For a stock trading below $1, NASDAQ issues a deficiency notice after 30 consecutive business days and generally allows a company up to 360 days to regain compliance before starting delisting procedures. Recent rule changes in early 2025 created stricter circumstances that can accelerate this timeline significantly.
NASDAQ delisting timeline
30 consecutive business days below $1: If a company's closing bid price is below $1 for 30 consecutive business days, NASDAQ sends the company a notice of non-compliance.
Initial 180-day grace period: The company has 180 calendar days from the deficiency notice date to fix the issue. To regain compliance, the closing bid price must be $1 or higher for at least 10 consecutive business days during this period.

Potential second 180-day grace period: After the first period expires, a company may be eligible for a second 180-day grace period. This is often available to companies on the Nasdaq Capital Market if they meet other listing requirements and notify NASDAQ of their intent to regain compliance.

Immediate suspension after 360 days: Under new rules approved in early 2025, if a company fails to regain compliance after the second 180-day grace period (a total of 360 days), it will face immediate suspension and delisting. A request for a hearing will no longer automatically stay the delisting process, and the stock would trade over-the-counter during any appeal.